Recent Research Funding

We receive funding from a variety of sources that recognize the value of our high-impact research.

Michael Duffey, PhD

  • Investigating the Action and Physiological Role of Slc4a11 in the Cornea. Michael Duffey (Co-Investigator), Mark Parker (Principal Investigator), Sangita Patel (Co-Investigator). National Institutes of Health. $1,972,804. 2/1/2018-1/1/2023.

Jian Feng, PhD

  • A Novel Epigenetic Mechanism for Alzheimer's Disease. Jian Feng (Co-Investigator), Zhen Yan (Principal Investigator). NIH. $1,993,750. 4/1/2017-3/1/2022.
  • Understand the Pathophysiology of Parkinson's Disease Using Genetically Modified iPS Cells. Jian Feng (Principal Investigator). NYSTEM. 6/1/2014-5/1/2017.
  • Kinetic Barriers of Transdifferentiation. Jian Feng (Principal Investigator). Department of Veterans Affairs. 4/1/2014-3/1/2018.
  • Redefining Idiopathic Parkinson’s Disease through Induced Pluriopotent Stem Cells. Jian Feng (Principal Investigator). NYSTEM. 3/1/2013-2/1/2016.

Wilma Hofmann, PhD

  • Role of myosin IC in prostate cancer metastasis. Wilma Hofmann (Principal Investigator). NIH/NCI. $478,500. 8/1/2017-7/1/2020.
  • Defining the link between obesity and aggressive prostate cancer. Wilma Hofmann (Principal Investigator). DoD CDMRP. $598,000. 9/1/2014-9/1/2017.

Mark Parker, PhD

  • Investigating the Action and Physiological Role of Slc4a11 in the Cornea. Mark Parker (Principal Investigator), Michael Duffey (Co-Investigator), Sangita Patel (Co-Investigator). National Institutes of Health. $1,972,804. 2/1/2018-1/1/2023.

Zhen Yan, PhD

  • A Novel Epigenetic Mechanism for Alzheimer's Disease. Zhen Yan (Principal Investigator), Jian Feng (Co-Investigator). NIH. $1,993,750. 4/1/2017-3/1/2022.
  • Novel Therapeutic Strategies for Autism. Zhen Yan (Principal Investigator). Nancy Lurie Marks Family Foundation. $540,000. 2/1/2016-1/1/2019.
  • Physiological and Pathophysiological Basis of Stress. Zhen Yan (Principal Investigator). NIH. $1,993,750. 7/1/2015-6/1/2020.
  • Functions of D4 Dopamine Receptors in Prefrontal Cortex. Zhen Yan (Principal Investigator). NIH. $1,590,000. 7/1/2014-6/1/2019.
  • A Novel Pathophysiological Mechanism of Alzheimer's Disease. Zhen Yan (Principal Investigator). Department of Veterans Affairs. $600,000. 4/1/2013-9/1/2017.